GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Pre-Tax Income

Wai Yuen Tong Medicine Holdings (HKSE:00897) Pre-Tax Income : HK$46 Mil (TTM As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Wai Yuen Tong Medicine Holdings's pretax income for the six months ended in Sep. 2023 was HK$38 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was HK$46 Mil. Wai Yuen Tong Medicine Holdings's pretax margin was 5.66%.

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest Pretax Margin was 73.33%. The lowest was -27.34%. And the median was 1.30%.


Wai Yuen Tong Medicine Holdings Pre-Tax Income Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Pre-Tax Income Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.69 455.17 -303.13 -47.30 -11.94

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.29 -101.59 -19.02 7.09 38.43

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wai Yuen Tong Medicine Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Pre-Tax Income falls into.



Wai Yuen Tong Medicine Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Wai Yuen Tong Medicine Holdings's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=84.271+0+-106.306+11.128+-1.029
=-12

Wai Yuen Tong Medicine Holdings's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=66.683+0+-57.79+5.394+24.142
=38

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Pre-Tax Income Explanation

Wai Yuen Tong Medicine Holdings's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=38.429/678.804
=5.66%

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest Pretax Margin was 73.33%. The lowest was -27.34%. And the median was 1.30%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines